A detailed history of Israel Englander (Millennium Management LLC) transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 26,300 shares of IMMX stock, worth $46,814. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,300
Previous 54,281 51.55%
Holding current value
$46,814
Previous $166,000 68.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.81 - $3.06 $50,645 - $85,621
-27,981 Reduced 51.55%
26,300 $52,000
Q1 2024

May 15, 2024

BUY
$2.64 - $6.68 $143,301 - $362,597
54,281 New
54,281 $166,000

Others Institutions Holding IMMX

About Immix Biopharma, Inc.


  • Ticker IMMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,910,100
  • Market Cap $24.8M
  • Description
  • Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...
More about IMMX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.